Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder – AAN 2018 [PDF]
Presented at the American Association of Neurology in Los Angeles, California; April 2018
NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.
Posters & Publications
- RT @identifor: RT @Surviving_SpEd 12 Easy Steps to Creating the Most Comprehensive IEP https://t.co/ys7aLdsuIY via @AutismParentMag https:…about 1 hour ago
- NeuroPointDX’s CEO, Beth Donley will be speaking at the 2019 @bioconvention in Philadelphia, June 3-6. Beth will be… https://t.co/2v94tMu7fI2 hours ago
- A new study found that using two screening tools for autism, the SWYC and the M-CHAT, detected 75% of the children… https://t.co/i8J6gDg8An6 hours ago